Sponsor or institution
Clinical trials and research at Hanmi Pharmaceutical Company Limited
As of November 12, 2026, Find a Trial lists 9 clinical trials run by Hanmi Pharmaceutical Company Limited that are recruiting, at sites in 8 countries (most in South Korea (7), United States (5), Belgium (1)). 1 was first registered in the last 30 days. By phase: Phase 1 (3), Phase 2 (3), Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1New in 30 days
- 8Countries
Newest trials
All recruiting trials (9)
-
HIP2602 for Erectile Dysfunction: Testing a new treatment in adults
This study tests whether HIP2602, alone or with related formulations, can improve erectile function in adult men with long-standing erectile dysfunction who partner with the same adult female partner.
-
Sequential triple combo therapy for hypertension in Korean adults
This study tests whether taking amlodipine/losartan/chlorthalidone in sequence helps Korean adults with high blood pressure feel better and stay safe.
-
HM15275 in adults with type 2 diabetes who have not yet reached goal
This phase 2 trial tests HM15275 or a placebo to see if it helps adults with type 2 diabetes improve blood sugar over 36 weeks.
-
Belvarafenib plus cobimetinib for NRAS-mutant advanced or metastatic melanoma
This trial will test whether taking belvarafenib with cobimetinib can shrink tumors or control disease in adults with NRAS‑mutant advanced or metastatic melanoma.
-
HM11260C added to metformin and dapagliflozin for adults with type 2 diabetes
We will test whether adding HM11260C helps adults with type 2 diabetes whose blood sugar isn't controlled on metformin and dapagliflozin.
-
Testing HM17321 injections to find safe dose ranges in healthy and obese adults
This study will try single and multiple doses of HM17321 injections in healthy adults and adults with obesity to see if they are safe and how the body processes the drug.
-
Testing HM16390 for advanced or metastatic solid tumors
This study is testing a new treatment called HM16390 for people with advanced or metastatic solid tumors who haven't had success with other therapies to see if it can help them.
-
Testing BH3120 alone or with pembrolizumab for advanced solid tumors
This study is testing a new treatment called BH3120, both alone and with another drug called pembrolizumab, to see if it can help people with advanced solid tumors.
-
Assessing a new treatment for Short Bowel Syndrome
This study is testing a new treatment for adults with Short Bowel Syndrome to see if it can help improve their condition compared to a placebo.
Quick answers
How many clinical trials run by Hanmi Pharmaceutical Company Limited are recruiting right now?
9, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in South Korea (7 trials), United States (5 trials), Belgium (1 trial), Denmark (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2: 3, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.